TOUJEO Max 300 U/mL (Insulin Glargine INJECTION, SOLUTION) 300 U/mL

TOUJEO Max 300 U/mL is a long-acting insulin glargine injection designed for subcutaneous use. This solution is formulated to provide consistent blood sugar control in diabetic patients, offering a convenient 3 mL syringe option.

Strength

300 U/mL

Pack Size

2 SYRINGE in 1 CARTON (0024-5871-02) / 3 mL in 1 SYRINGE (0024-5871-00)

Manufacturer / TM Owner

Sanofi-Aventis U.S. LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TOUJEO Max 300 U/mL is primarily used for the management of diabetes mellitus in adults. This insulin glargine injection helps regulate blood sugar levels over an extended period, supporting daily glucose control. Patients often inquire about what insulin glargine is used for, and it is commonly prescribed for those requiring long-term insulin therapy.

Side Effects

Common effects of TOUJEO Max 300 U/mL may include localized reactions at the injection site, such as redness or itching. Some users experience hypoglycemia, characterized by symptoms like sweating, dizziness, or confusion. These effects are generally mild and temporary, but consistent monitoring is advised.

Precautions & Warnings

TOUJEO Max 300 U/mL should be stored properly to maintain its efficacy. It is essential to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Always check the solution for particles or discoloration before use, and avoid sharing syringes to prevent infection.

Avoid Interactions

TOUJEO Max 300 U/mL may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Alcohol consumption can also affect blood sugar levels, so moderation is advised. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

TOUJEO Max 300 U/mL is used for the management of diabetes mellitus in adults, providing long-acting insulin to regulate blood sugar levels.

TOUJEO Max 300 U/mL is administered subcutaneously, typically in the abdomen, thigh, or upper arm, using the provided syringe.

Common side effects may include localized reactions at the injection site and symptoms of hypoglycemia, such as sweating or dizziness.

TOUJEO Max 300 U/mL may interact with other diabetes medications, so it is important to consult a healthcare provider before combining treatments.

TOUJEO Max 300 U/mL should be stored in a refrigerator between 36°F to 46°F (2°C to 8°C) and kept away from direct light and heat.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.